AGA Amplatzer Pivotal Study Investigator Draws FDA Warning Letter
This article was originally published in The Gray Sheet
Executive Summary
A principal investigator in AGA Medical's Amplatzer septal occluder pivotal study, currently under PMA review, was cited in an FDA warning letter for failure to properly report issues of informed consent, patient follow-up and compassionate use of the device